Breast Neoplasm
1 competing product in clinical development for Breast Neoplasm.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Fulvestrant | Eli Lilly | Phase 2 | Terminated | 52 |
1 competing product in clinical development for Breast Neoplasm.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Fulvestrant | Eli Lilly | Phase 2 | Terminated | 52 |